Seasonal influenza viruses circulate all year in the United States, but the Centers for Disease Control and Prevention (CDC) says flu season usually occurs in the fall and winter. CDC reports that flu activity most often peaks between December and February. CDC tracks flu with a nationwide surveillance system and publishes weekly summaries called FluView and FluView Interactive.

When flu season happens in the United States

CDC states that influenza viruses circulate year-round, with typical increases in fall and winter during what is known as flu season. For the 1982–1983 through 2023–2024 seasons, CDC reports that flu activity most often peaked in February, followed by December, January, and March. CDC also notes that the overall health impact of flu, including infections, hospitalizations, and deaths, varies from season to season.

What CDC monitors each week

According to CDC, the U.S. influenza surveillance system is a collaborative effort with state, local, and territorial health departments; public health and clinical laboratories; vital statistics offices; health care providers; hospitals; clinics; and emergency departments. CDC says the system is designed to find when and where influenza is occurring, determine what viruses are circulating, detect changes in those viruses, and measure impact on illness, hospitalizations, and deaths. FluView and FluView Interactive are updated weekly, and CDC notes that each week’s data are preliminary and may change as more data are received.

How labs track the virus

CDC’s virologic surveillance uses the U.S. Influenza Collaborating Laboratories System and the National Respiratory and Enteric Virus Surveillance System. CDC explains that clinical laboratories mainly provide information about timing and intensity by reporting how many respiratory specimens test positive for influenza, while public health laboratories focus on the types, subtypes, and lineages of viruses and the ages of people infected. CDC considers a change of 0.5 percentage points or more in the clinical-lab percent positive to be increasing or decreasing compared with the prior week; smaller changes are considered stable.

CDC conducts virus characterization to assess how similar circulating viruses are to vaccine reference viruses and to monitor evolutionary changes. Genetic characterization uses next-generation sequencing and groups viruses by hemagglutinin clades and subclades, and antigenic characterization uses laboratory assays to compare how antibodies raised against vaccine reference viruses recognize circulating viruses. CDC also tests a subset of viruses for susceptibility to influenza antivirals and reports results in FluView.

CDC explains that influenza viruses undergo minor changes, called antigenic drift, and can also undergo abrupt, major change, called antigenic shift. Surveillance can detect these changes and inform the public health response. CDC also conducts surveillance for novel influenza A viruses; human infections with influenza A viruses that are different from seasonal A(H1) and A(H3) are nationally notifiable and are reported in FluView and FluView Interactive.

How outpatient illness is tracked

CDC’s U.S. Outpatient Influenza-like Illness Surveillance Network (ILINet) collects data on outpatient visits for influenza-like illness, called ILI, from providers across all states and territories. For this system, CDC defines ILI as a fever of at least 100°F (37.8°C) with a cough and/or sore throat. Because ILINet tracks symptoms rather than laboratory-confirmed infections, CDC says these data should be evaluated with other surveillance components.

CDC combines state data weighted by state population to produce the national weekly percentage of outpatient visits for ILI. CDC considers a change of more than 0.1 percentage points in the ILI percentage to be increasing or decreasing compared with the prior week; smaller changes are considered stable. CDC also compares the weekly ILI percentage to a national baseline; during the 2025–2026 season, CDC set the national baseline at 3.1% based on non-influenza weeks from the prior three seasons, and developed region-specific baselines using the same method.

CDC produces an ILI Activity Indicator Map that compares a jurisdiction’s current ILI percentage with its own non-influenza-week average. Activity levels reflect intensity, not geographic spread, and are classified from minimal to very high based on standard deviations above the mean for non-influenza weeks. CDC notes that outbreaks in a single area can raise a jurisdiction’s level and that ILINet data may not represent all populations within a jurisdiction.

CDC also uses emergency department data through the National Syndromic Surveillance System. According to CDC, about 83% of U.S. emergency departments send data to this system, often within 24 hours, allowing CDC to track the percentage of emergency department visits with an influenza diagnosis overall and by age group.

How hospitalizations are tracked

CDC monitors laboratory-confirmed influenza-associated hospitalizations through multiple systems. The Influenza Hospitalization Surveillance Network (FluSurv-NET) conducts population-based surveillance in more than 90 counties across 14 states and represents more than 34 million people, about 10% of the U.S. population, as of Jan. 30, 2026, according to CDC. FluSurv-NET reports weekly hospitalization rates by age group and collects clinical details on sampled patients to describe characteristics and outcomes. Starting with the 2025–2026 season, CDC reports that FluSurv-NET collects data year-round.

CDC also compiles required weekly reporting from all acute care and critical access hospitals through the National Healthcare Safety Network’s Hospital Respiratory Data Module. Facilities report bed capacity and occupancy and counts of patients hospitalized with laboratory-confirmed influenza, along with new hospital admissions by age group. For monitoring week-to-week changes in these national and regional data, CDC considers a change of 0.2 or more in the rate of new hospital admissions per 100,000, or a change of 691 or more in the number of new admissions, to be increasing or decreasing; smaller changes are considered stable.

Long-term care facilities report weekly case, hospitalization, and vaccination data for respiratory pathogens to CDC’s National Healthcare Safety Network Long-Term Care Respiratory Pathogens and Vaccination Module. CDC calculates influenza-related hospitalization rates for residents and classifies week-to-week changes of 5% or more as increasing or decreasing; smaller changes are considered stable. CDC notes that the data-collection week in this module runs Monday through Sunday, which differs slightly from other influenza surveillance components.

How deaths are tracked

CDC’s National Center for Health Statistics collects death-certificate data from state vital statistics offices for all United States deaths and classifies deaths associated with influenza, COVID-19, and pneumonia using ICD-10 codes. CDC tracks three measures: pneumonia and/or influenza (P&I); pneumonia, influenza, and/or COVID-19 (PIC); and influenza-only (I). CDC displays the percent of deaths with influenza listed on the death certificate to track influenza-specific mortality trends and provides P&I and PIC baselines and thresholds on FluView Interactive.

CDC says the PIC and P&I percentages are compared with a seasonal baseline calculated using a periodic regression model, and an increase of 1.645 standard deviations above baseline is considered the epidemic threshold. CDC notes that P&I and PIC are influenced by COVID-19 patterns, and influenza-only coded deaths underestimate the full impact of influenza mortality but allow tracking of influenza-specific trends.

Why weekly reports have a short delay

CDC explains that the surveillance reporting week runs Sunday through Saturday. Participants summarize data and submit to CDC by the following Tuesday afternoon. CDC downloads, compiles, and analyzes the information, then updates FluView and FluView Interactive on Friday, which creates about a one-week lag between events and reporting.

Other respiratory viruses during flu season

CDC notes that several other respiratory viruses circulate during flu season and can cause similar symptoms. These include rhinovirus, the virus that causes COVID-19, and respiratory syncytial virus, along with human parainfluenza viruses, human metapneumovirus, respiratory adenoviruses, and human coronaviruses other than those that cause COVID-19. CDC also provides integrated information about COVID-19, influenza, and RSV activity from emergency department data on a website that is updated weekly.